SEARCH RESULT

Total Matching Records found : 71

Points of law in the PepsiCo-potato case -Biswajit Dhar

-The Hindu Business Line India’s Protection of Plant Varieties Act spells out rights of farmers vis-a-vis breeders, which resulted in a pushback for PepsiCo The Protection of Plant Varieties and Farmers’ Rights Act (PPVFRA), which introduced intellectual property protection in Indian agriculture, faced its biggest test in its implementation phase of nearly a decade and a half, when PepsiCo India initiated legal proceedings against four farmers in Gujarat for “illegally” growing...

More »

Ending TB -Jayalakshmi Shreedhar & Anupama Srinivasan

-The Hindu The disease cannot be eliminated without universal access to affordable, quality diagnostics and drugs After decades spent battling the scourge of tuberculosis (TB) in developing countries, 2018 might be the year that it is finally accorded the gravitas it deserves. On September 26, the UN General Assembly will, for the first time, address TB in a High-Level Meeting and likely release a Political Declaration, endorsed by all member nations, to...

More »

What's at stake in Hyderabad -Feroz Ali

-The Hindu India must counter Japan’s U.S.-style pressure at the RCEP talks and ensure affordable generic medicines Leaked texts are like leaked gases — you may never find the one responsible for it, but the mayhem caused by its release is hard to contain. Unsurprisingly, all public discussions on the Regional Comprehensive Economic Partnership (RCEP) are centred around leaked documents. As India negotiates the RCEP — a free trade agreement that looks...

More »

New Zealand Negotiator at Asia Trade Pact Talks Says Countries Should Analyse TRIPS-Plus -Anoo Bhuyan

-TheWire.in The negotiator’s comments were non-committal but indicated that for now, the RCEP talks have not yet moved decisively into a TRIP-plus scenario. The chief negotiator for New Zealand, at the Asia trade pact talks in Hyderabad this week, made pointed reference to TRIPS-plus (Trade-Related Aspects of Intellectual Property Rights) provisions, saying that while the TRIPS agreement on intellectual property rights was sufficient, it was up to the countries to analyse whether...

More »

Validation of India's drug patent policy -Latha Jishnu

-Down to Earth A high level UN panel on Access to Medicines wants members to make full use of TRIPS flexibilities to protect public health If ever India needed a clear endorsement of its laws on intellectual property rights (IPRs) and their application in meeting public health priorities, it has come from the highest quarters. The report of the UN Secretary General’s High Level Panel (HLP) on Access to Medicines has, directly...

More »

Video Archives

Archives

share on Facebook
Twitter
RSS
Feedback
Read Later

Contact Form

Please enter security code
      Close